Melissa Kotterman
Private Equity Investor bei Berkeley Frontier Fund
Ursprung des Netzwerks ersten Grades von Melissa Kotterman
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
University of California, Berkeley
344
| College/University | Other Consumer Services | 344 |
Berkeley Frontier Fund
 Berkeley Frontier Fund Investment ManagersFinance Berkeley Frontier Fund (Berkeley Frontier Fund) is a venture capital firm founded in 202. The firm is headquartered in Berkeley, California.
29
| Private Company | Investment Managers | 29 |
| Public Company | Biotechnology | 26 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Melissa Kotterman
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| CELGENE | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Hall Capital Partners LLC
 Hall Capital Partners LLC Investment ManagersFinance Hall Capital Partners LLC (HCP) is an independent, SEC-registered investment advisor and wealth management firm headquartered in San Francisco, California. The firm was founded by Kathryn Hall in 1994. HCP advises on and manages multi-asset class portfolios for families, endowments, foundations, and other clients. | Investment Managers | Analyst-Equity Analyst-Equity | |
Global Alliance for TB Drug Development
 Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | Pharmaceuticals: Generic | Director/Board Member | |
| ALDEYRA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
SillaJen Biotherapeutics, Inc.
 SillaJen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services SillaJen Biotherapeutics, Inc. develops and commercializes cancer therapeutics. It focuses on the development and commercialization of first-in-class, breakthrough targeted oncolytic immunotherapy products for solid tumors. It is focused on two main programs, lead product candidate, which is in mid-stage clinical development for the treatment of advanced primary liver cancer and colorectal cancer and JX-929 which is under investigation for a variety of other solid tumors. The company was founded by John C. Bell and David H. Kirn in 2006 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Founder Chief Tech/Sci/R&D Officer | |
| KADMON HOLDINGS, INC. | Biotechnology | Director/Board Member | |
| Brown University | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree | |
Morgan Stanley & Co. LLC
 Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Morgan Stanley & Co. LLC is a registered broker-dealer subsidiary of Morgan Stanley Domestic Holdings, Inc., ultimately owned by Morgan Stanley (NYSE: MS) in the US. Headquartered in New York City, the firm was founded in 1987 and provides debt and equity services including underwriting, M&A advice, securities dealing and brokerage and trade execution. Their client base ranges from large global institutional investors to hedge funds at the cutting edge of innovation in the industry. | Investment Banks/Brokers | Analyst-Equity Corporate Officer/Principal | |
| Stanford University | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree Doctorate Degree | |
| UDG HEALTHCARE PLC | Miscellaneous Commercial Services | Director/Board Member | |
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
| University of Oxford | College/University | Corporate Officer/Principal Graduate Degree | |
Barclays Capital, Inc.
 Barclays Capital, Inc. Investment Banks/BrokersFinance Barclays Capital, Inc. is a registered broker/dealer headquartered in New York City. The firm was founded in 1997 and is a subsidiary of Barclays Group US, Inc., ultimately owned by Barclays plc (LON: BARC) in Great Britain. Barclays Capital provides large corporate, government and institutional clients a full spectrum of prime brokerage services which includes equities and fixed income financing, OTC Clearing, Futures and Foreign Exchange Prime Brokerage and access to industry insights and analytics from their Strategic Consulting team. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
| University of California, Los Angeles | College/University | Doctorate Degree Masters Business Admin | |
| Queen's University | College/University | Undergraduate Degree Undergraduate Degree | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree Doctorate Degree | |
| Indiana University | College/University | Undergraduate Degree Doctorate Degree | |
| Ithaca College | College/University | Undergraduate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree | |
| Princeton University | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
| The University of California, San Francisco | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| London School of Economics & Political Science | College/University | Graduate Degree Graduate Degree | |
| University of Sao Paulo | College/University | Graduate Degree | |
Industry Ventures LLC
 Industry Ventures LLC Investment ManagersFinance Industry Ventures LLC (Industry Ventures) is a venture capital firm founded in 2000 by Johan Douwe Swildens and Tom Litle. The firm is headquartered in San Francisco, California. | Investment Managers | Private Equity Investor | |
Certent, Inc.
 Certent, Inc. Packaged SoftwareTechnology Services Certent, Inc. provides software and services for equity compensation and financial disclosure management and reporting. It offers equity management & reporting, equity administration, equity financial reporting, broker & HR payroll, cap table management, profit interest units, internal reporting, external reporting, disclosure research, regulatory filing research and accounting standards. The firm's services include: equity compensation services, financial & regulatory reporting services, training & education, support services and learning & resources. The company was founded in 2002 and is headquartered in Roseville, CA. | Packaged Software | Chairman | |
The Column Group LLC
 The Column Group LLC Investment ManagersFinance The Column Group LLC is a venture capital firm founded in 2005 by Peter Svennilson. The firm is headquartered in San Francisco. | Investment Managers | Private Equity Investor Private Equity Investor | |
| Haas School of Business | College/University | Undergraduate Degree Corporate Officer/Principal Masters Business Admin Undergraduate Degree Undergraduate Degree Masters Business Admin Masters Business Admin Masters Business Admin | |
| University of Caxias do Sul | College/University | Corporate Officer/Principal | |
Caixa Estadual SA - Agência de Fomento RS
 Caixa Estadual SA - Agência de Fomento RS Financial ConglomeratesFinance Caixa Estadual SA - Agência de Fomento RS is a company based in Porto Alegre, Brazil. The Brazilian company engages in the growth and development of the state. It is ultimately controlled by the State of Rio Grande do Sul. | Financial Conglomerates | Corporate Officer/Principal | |
| University of California | College/University | Doctorate Degree Corporate Officer/Principal Undergraduate Degree Doctorate Degree | |
Raine Capital LLC
 Raine Capital LLC Investment ManagersFinance Raine Capital LLC (Raine) is a registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Joseph Ravitch and Jeffrey A. Sine in 2009. They are a wholly-owned subsidiary of The Raine Group LLC, a Delaware limited liability company, which is principally owned by Raine Holdings LLC. Raine provides investment advisory services on a discretionary basis to certain closed-end private investment funds and certain open-end private investment funds. | Investment Managers | Analyst-Equity | |
Ironfire Ventures
 Ironfire Ventures Investment ManagersFinance Ironfire Ventures (Ironfire Ventures) is a venture capital subsidiary of Ironfire Capital LLC founded in 2012 by Eric Jackson and Richard Chan. The firm is headquartered in San Francisco, California. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor | |
Ignite Immunotherapy, Inc.
 Ignite Immunotherapy, Inc. BiotechnologyHealth Technology Part of Pfizer Inc., Ignite Immunotherapy, Inc. is a company that designs and develops oncolytic virus vaccines. The company is based in New York, NY. The company was founded by David Schaffer, Douglas Hanahan, David H. Kirn, Theresa Janke, Melissa Kotterman. The CEO is Monika A. Vnuk. | Biotechnology | Founder Founder Founder | |
Berkeley Skydeck
 Berkeley Skydeck Investment ManagersFinance Berkeley Skydeck is a venture capital arm of University of California, Berkeley founded in 2012. The firm is headquartered in Berkeley, California. | Investment Managers | Consultant / Advisor Corporate Officer/Principal Consultant / Advisor | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| Columbia Business School | College/University | Masters Business Admin Masters Business Admin | |
| MIT Sloan School of Management | College/University | Masters Business Admin Masters Business Admin | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
Vicinitas Therapeutics
 Vicinitas Therapeutics BiotechnologyHealth Technology Vicinitas Therapeutics is located in the US. Vicinitas Therapeutics is an American US-based biotechnology company that specializes in developing next-generation disease therapies using targeted protein stabilizers called Deubiquituinase Targeting Chimeras (DUBtacs). The company's mission is to solve critical problems in human health by developing disease therapies against an entire class of previously inaccessible disease-causing proteins. | Biotechnology | Consultant / Advisor Founder | |
Attralus, Inc.
 Attralus, Inc. Pharmaceuticals: MajorHealth Technology Attralus, Inc. operates as a biopharmaceutical company. The firm focuses on illuminating the systemic nature of amyloidosis and creating transformative medicines to improve the lives of patients. The company was founded by Jonathan Wall in 2019 and is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member | |
TEN63 Therapeutics
 TEN63 Therapeutics Pharmaceuticals: MajorHealth Technology TEN63 Therapeutics provides drug development services. The American company was founded by Nancy Miller-Rich, Marcel Frenkel, Mark Hallen, Bruce Donald. Marcel Frenkel has been the CEO since incorporation. | Pharmaceuticals: Major | Founder | |
Necessary Ventures LLC
 Necessary Ventures LLC Investment ManagersFinance Necessary Ventures LLC (Necessary Ventures) is a venture capital firm founded in 2020 by Neil Devani. The firm is headquartered in San Francisco, California. | Investment Managers | Private Equity Analyst |
Statistik
International
| Vereinigte Staaten | 42 |
| Brasilien | 4 |
| Vereinigtes Königreich | 3 |
| Irland | 2 |
| Kanada | 2 |
Sektoral
| Consumer Services | 20 |
| Finance | 14 |
| Health Technology | 13 |
| Commercial Services | 3 |
| Technology Services | 3 |
Operativ
| Director/Board Member | 167 |
| Corporate Officer/Principal | 114 |
| Undergraduate Degree | 93 |
| Founder | 72 |
| Private Equity Investor | 61 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Alberto Luigi Sangiovanni-Vincentelli | 27 |
| Shawn Tomasello | 22 |
| Susannah Gray | 20 |
| Alfred Chu | 19 |
| Bill Burkoth | 19 |
| Jacob Chacko | 18 |
| Charles Huang | 17 |
| Roseanne Wincek | 17 |
| David Schaffer | 15 |
| Nancy Miller-Rich | 15 |
| David Kirn | 14 |
| Gary Yeung | 13 |
| Graham Walmsley | 13 |
| Daniel K. Nomura | 12 |
| Max Hui | 12 |
- Börse
- Insiders
- Melissa Kotterman
- Unternehmensverbindungen
